PA8441401A1 - Procedimiento para piridinas sustituidas - Google Patents

Procedimiento para piridinas sustituidas

Info

Publication number
PA8441401A1
PA8441401A1 PA19978441401A PA8441401A PA8441401A1 PA 8441401 A1 PA8441401 A1 PA 8441401A1 PA 19978441401 A PA19978441401 A PA 19978441401A PA 8441401 A PA8441401 A PA 8441401A PA 8441401 A1 PA8441401 A1 PA 8441401A1
Authority
PA
Panama
Prior art keywords
procedure
amino
piridines
substituted
formula
Prior art date
Application number
PA19978441401A
Other languages
English (en)
Inventor
Robert Lee Dow
Keith Michael Devries
Stephen Wayne Wright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PA8441401A1 publication Critical patent/PA8441401A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A PROCEDIMIENTOS PARA PREPARAR COMPUESTOS DE LA FORMULA(I) Y A PROCEDIMIENTOS PARA PREPARAR CIERTOS INTERMEDIOS DE LA FORMULA EN LA QUE R1 ES NITRO, AMINO O AMINO PROTEGIDOS; R2 ES H, FLUORO, CLORO, CF3, NITRO, ALQUILO(C1-C4), ALCOXI(C1-C4), AMINO O AMINO PROTEGIDO; Y X1 ES OH O UN GRUPO SALIENTE ADECUADO, USADO EN ESTE PROCEDIMIENTO. LA INVENCION TAMBIEN SE REFIERE A NUEVOS COMPUESTOS DE FORMULA (II).
PA19978441401A 1996-11-14 1997-11-12 Procedimiento para piridinas sustituidas PA8441401A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3088096P 1996-11-14 1996-11-14

Publications (1)

Publication Number Publication Date
PA8441401A1 true PA8441401A1 (es) 2000-05-24

Family

ID=21856496

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978441401A PA8441401A1 (es) 1996-11-14 1997-11-12 Procedimiento para piridinas sustituidas

Country Status (32)

Country Link
US (1) US6291489B1 (es)
EP (1) EP0938476B1 (es)
JP (1) JP3510635B2 (es)
KR (1) KR20000053314A (es)
CN (1) CN1237160A (es)
AP (1) AP805A (es)
AR (1) AR010584A1 (es)
AT (1) ATE319687T1 (es)
AU (1) AU4634697A (es)
BG (1) BG103393A (es)
BR (1) BR9712951A (es)
CA (1) CA2270386C (es)
CO (1) CO4930261A1 (es)
DE (1) DE69735433D1 (es)
EA (1) EA199900375A1 (es)
GT (1) GT199700118A (es)
HR (1) HRP970612A2 (es)
ID (1) ID18898A (es)
IL (1) IL129688A0 (es)
IS (1) IS5029A (es)
MA (1) MA24401A1 (es)
MY (1) MY132507A (es)
NO (1) NO992296D0 (es)
OA (1) OA11044A (es)
PA (1) PA8441401A1 (es)
PE (1) PE10299A1 (es)
TN (1) TNSN97172A1 (es)
TR (1) TR199901063T2 (es)
UY (1) UY24774A1 (es)
WO (1) WO1998021184A1 (es)
YU (1) YU22099A (es)
ZA (1) ZA9710186B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002511460A (ja) * 1998-04-08 2002-04-16 ノバルティス アクチエンゲゼルシャフト 新規除草剤
US6090942A (en) * 1998-10-15 2000-07-18 Pfizer Inc. Process and intermediates for a β3 -adrenergic receptor agonist
CA2362070A1 (en) 1999-02-16 2000-08-24 Masaru Mitsuda Substituted acetylpyridine derivatives and process for the preparation of intermediates for optically active .beta.3 agonist by the use of the same
US6455734B1 (en) * 2000-08-09 2002-09-24 Magnesium Diagnostics, Inc. Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states
DE60015036T2 (de) * 1999-07-23 2006-03-02 Pfizer Products Inc., Groton Zwischenprodukte und ein Verfahren zur Herstellung von beta3-Adrenergischer Rezeptor-Agoniste
US20040265991A1 (en) * 2001-10-17 2004-12-30 Naoaki Taoka Process for preparation of (s)-alpha-halomethylpyridine-methanol derivatives
US6864268B2 (en) 2002-02-27 2005-03-08 Pfizer Inc. β3 adrenergic receptor agonists
AU2003209527A1 (en) * 2002-02-27 2003-09-09 Pfizer Products Inc. Crystal forms of (r)-2-(2-(4-oxazol-4-yl-phenoxy)-ethylamino)-1-pyridin-3-yl-ethanol
BR0307996A (pt) 2002-02-27 2004-12-07 Pfizer Prod Inc Processos e intermediários úteis na preparação de receptores de agonistas beta3-adrenérgicos
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
JP4454622B2 (ja) 2003-05-09 2010-04-21 エフ．ホフマン−ラ ロシュ アーゲー アルファ−１アドレナリン作動性アゴニストとしてのメチルインドール及びメチルピロロピリジン
GB2431927B (en) 2005-11-04 2010-03-17 Amira Pharmaceuticals Inc 5-Lipoxygenase-activating protein (FLAP) inhibitors
US7977359B2 (en) 2005-11-04 2011-07-12 Amira Pharmaceuticals, Inc. 5-lipdxygenase-activating protein (FLAP) inhibitors
US8399666B2 (en) 2005-11-04 2013-03-19 Panmira Pharmaceuticals, Llc 5-lipoxygenase-activating protein (FLAP) inhibitors
WO2010068311A1 (en) 2008-05-23 2010-06-17 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358455A (en) 1980-12-23 1982-11-09 Merck & Co., Inc. Aralkylamindethanol heterocyclic compounds
US5019578A (en) 1987-11-27 1991-05-28 Merck & Co., Inc. β-adrenergic agonists
PL312005A1 (en) 1993-06-14 1996-04-01 Pfizer Binary amines as antidiabetic and antiobesitic agents
IL113410A (en) * 1994-04-26 1999-11-30 Merck & Co Inc Substituted sulfonamides having an asymmetric center and pharmaceutical compositions containing them
JPH11504648A (ja) 1995-05-10 1999-04-27 ファイザー・インコーポレーテッド β−アドレナリン作動性アゴニスト
MX9708621A (es) * 1995-05-10 1998-02-28 Pfizer AGONISTAS beta-ADRENERGICOS, COMPOSICIONES QUE LOS CONTIENEN Y USO DE LOS MISMOS.

Also Published As

Publication number Publication date
CA2270386C (en) 2004-08-03
BG103393A (en) 2000-07-31
US6291489B1 (en) 2001-09-18
IS5029A (is) 1999-04-16
KR20000053314A (ko) 2000-08-25
MY132507A (en) 2007-10-31
ID18898A (id) 1998-05-20
UY24774A1 (es) 1998-05-05
EP0938476A1 (en) 1999-09-01
AP9701147A0 (en) 1998-01-31
OA11044A (en) 2002-02-20
TNSN97172A1 (fr) 2005-03-15
CO4930261A1 (es) 2000-06-27
CA2270386A1 (en) 1998-05-22
HRP970612A2 (en) 1998-08-31
WO1998021184A1 (en) 1998-05-22
NO992296L (no) 1999-05-12
AU4634697A (en) 1998-06-03
CN1237160A (zh) 1999-12-01
GT199700118A (es) 1999-05-05
DE69735433D1 (de) 2006-05-04
PE10299A1 (es) 1999-02-10
TR199901063T2 (xx) 1999-08-23
JP3510635B2 (ja) 2004-03-29
AP805A (en) 2000-01-28
MA24401A1 (fr) 1998-07-01
EA199900375A1 (ru) 1999-12-29
EP0938476B1 (en) 2006-03-08
ZA9710186B (en) 1999-05-12
NO992296D0 (no) 1999-05-12
ATE319687T1 (de) 2006-03-15
IL129688A0 (en) 2000-02-29
BR9712951A (pt) 1999-12-07
AR010584A1 (es) 2000-06-28
JP2000504347A (ja) 2000-04-11
YU22099A (sh) 2001-09-28

Similar Documents

Publication Publication Date Title
PA8441401A1 (es) Procedimiento para piridinas sustituidas
ES2142034T3 (es) Compuestos biaromaticos que llevan un grupo adamantilo en orto, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
PA8521701A1 (es) Derivados de pirazol
PT83713B (pt) Processo para a preparacao de derivados de 4-benzil-1-(2h)-ftalazinona e de composicoes farmaceuticas que os contem
CO4780028A1 (es) Procedimiento para la preparacion de sildenafil
BR9304185A (pt) Método para a utilização de um selante de fibrina, método para a preparação de ume composição que compreende monõmero de fibrina a partir de fibrinogénio, composição aquosa, composição, kit e suporte sólido
RS50437B (sr) Benzoilpirazoli i njihova primena u ulozi herbicida
ES2163512T3 (es) Nuevo compuesto, procedimiento para producirlo, y agente antitumoral.
AU1180797A (en) Phenylimidazolidines and use thereof as an antiandrogenic agent
DK0634400T3 (da) Pyridincarboxyimidamidforbindelse og anvendelse deraf
YU19997A (sh) Analozi fluorovanog vitamina d3
BR9709570A (pt) Melhoramentos no efeito de herbicidas
ES2096344T3 (es) Sulfonilureas herbicidas, procedimiento para su obtencion y su empleo.
ES2189072T3 (es) Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PE20030346A1 (es) Proceso para la produccion de quinazolinas
GT199900113A (es) Inhibidores de las fkbp.
ES2076037T3 (es) Aminoesteres de los acidos 1,3,5-triacin-2,4,6-tris-alquilaminocarboxilicos, agentes biocidas que los contienen, asi como procedimiento para su fabricacion.
BR0211425A (pt) Método para a preparação de compostos, e, uso de uma composição
ES2114115T3 (es) Procedimiento y nuevos productos intermedios para la obtencion de triazolinonas.
SV1999000075A (es) Derivados de 3-(2-oxo-[1,3']bipirrolidinil-3-ilidenemetil)-cefemos
PE36098A1 (es) Nuevas heteroariloxazolidinonas
ES2155187T3 (es) Antagonistas biciclicos de taquicinas, preparacion de estos antagonistas y su utilizacion en compuestos farmaceuticos.
ES2145480T3 (es) Amidas de acido carbamoilcarboxilico.
BR9408078A (pt) Composto composição herbicida e processo para controlar vegetação indesejável
ECSP972312A (es) Procedimiento para piridinas sustituidas